| Similar Articles |
|---|
 |
The Motley Fool
August 4, 2004
Roger Nusbaum |
Inamed Waiting for Good News This multifaceted medical device company, which sells breast implants, awaits an FDA decision. The biggest risk is the stock getting caught in a general health sector downturn.   |
The Motley Fool
January 23, 2004
Jean Graham |
Keeping Abreast of Implants Inamed's race with Mentor for first rights to the silicone breast implant market hits a snag. |
Salon.com
October 9, 2000
Denise Dowling |
Covering up the breast The National Cancer Institute decides not to publicize the results of a publicly funded study of the safety of silicone breast implants. What's the deal? |
BusinessWeek
April 25, 2005
Catherine Arnst |
Breast Implants: Science vs. Emotion Lobbying and politics are having a huge effect on the debate over whether to allow silicone breast implants back on the market. |
The Motley Fool
November 22, 2006
Brian Lawler |
Implant Approval Gives Allergan a Lift The return of silicone breast implants continues. Shares of Allergan, best known for its Botox wrinkle treatment, were up nearly 8% on the news. |
The Motley Fool
April 14, 2005
Rich Duprey |
Mentor the Winner on Implants An FDA panel gives Mentor the right to market breast implants after denying Inamed's application. On the news, Inamed's stock fell by more than 3%, and then nearly 7% in early morning trading. |
The Motley Fool
May 19, 2006
Jim Mueller |
Foolish Forecast: Mentor's Uncertain Results Factors outside of the cosmetic surgery products maker's control are leading to short-term uncertainty. Investors, take note. |
Chemistry World
January 7, 2010
Rajendrani Mukhopadhyay |
Chemists slam Science paper A paper published in the prestigious journal Science has caused a commotion in the chemistry community, with the synthetic processes discussed in the paper dismissed as nonsense and accusations of a failure in Science's peer review system. |
BusinessWeek
December 25, 2006
Palmeri & Weintraub |
Silicone Goes Subtle Allergan's campaign relies on friendly persuasion. |
The Motley Fool
February 9, 2006
Stephen D. Simpson |
Mentor Needs Some Prettying Up Until new products are approved or acquired, the aesthetics and urology company seems stuck in suspended animation. Just standing in place is not going to build much shareholder value. |
The Motley Fool
August 8, 2006
Stephen D. Simpson |
Waiting on Fine Figures From Mentor Flush with cash, medical aesthetics specialist Mentor needs to reinvest in growth. This is a fine company that rarely trades cheap -- investors, take note. |
Chemistry World
August 22, 2006
Katharine Sanderson |
Open Access for Chemistry The team that developed BioMed Central, an open access publishing website, has launched a chemistry version called Chemistry Central. |
Nutra Solutions
July 1, 2005 |
Soy Claims Count Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%, reports a study published in The International Journal of Cancer Prevention. |
The Motley Fool
June 3, 2004
Mark Mahorney |
Breast Enhancer Bounces Back Dow Corning emerges from bankruptcy after nine years spent protecting itself from several hundred thousand suing women who claimed that ruptured silicone breast implants made by the company were the cause of autoimmune diseases. Now what? |
Reactive Reports
Issue 45 |
Star Picks Chemistry Web sites: Chemists Celebrate Earth Day: Resources... Doing Chemistry... Chemistry Question... |
BusinessWeek
April 25, 2005
Catherine Arnst |
When Patients Say: Don't Ban My Drug Emotional lobbying can keep a treatment on the market despite serious side effects. |
| AskMen.com |
Ill-Gotten Gains Authorities say a Texas woman lied about having breast cancer and spent $10,000 raised at a benefit to have her breasts enlarged. |
Chemistry World
December 2007
Richard Van Noorden |
Surfing Web2O The rapid evolution of the world wide web is creating fresh opportunities - and challenges - for chemistry. |
Reactive Reports
Issue 67
David Bradley |
Reactive Profile--Bryan Vickery, Chemistry Central Having ruined too many pairs of jeans, this chemist opted for a desk job instead of a bench job. He is currently Publisher at BioMed Central with special interest in Chemistry Central. |
